Yuka Sugawara

University of Tokyo Hospital

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Collaborators (4)

Masaomi Nangaku

Graduate School of Medicine, The University of Tokyo

JAPAN

View details

Koki Mise

Okayama University

JAPAN

View details

Naoki Nakagawa

Asahikawa Medical University

JAPAN

View details

Yasuhiro Onishi

Assistant professor

Okayama University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Yuka Sugawara

Research Interests

Explore related searches

Contact this professor

Articles (10)

Coronavirus Disease 2019 Vaccination Booster Effectiveness Based on the 2022 Japanese Dialysis Registry

Pathogenic variants prevalence patients with diabetic kidney disease in Japan: A descriptive study

Metrics for Evaluating Telemedicine in Randomized Controlled Trials: Scoping Review

Authors’ Reply: Japan's Telepsychiatry Dissemination: Current Status and Challenges

Coronavirus disease 2019 vaccination effectiveness based on the 2021 Japanese dialysis registry

Correction: Issues in the Adoption of Online Medical Care: Cross-Sectional Questionnaire Survey

Telemedicine in nephrology: future perspective and solutions

Issues in the Adoption of Online Medical Care: Cross-Sectional Questionnaire Survey

Kidney outcomes associated with haematuria and proteinuria trajectories among patients with IgA nephropathy in real‐world clinical practice: The Japan Chronic Kidney Disease Database

Analysis of inflammatory cytokines and estimated glomerular filtration rate decline in Japanese patients with diabetic kidney disease: a pilot study

Collaborators (4)

Masaomi Nangaku

Koki Mise

Naoki Nakagawa

Yasuhiro Onishi

Make your next move.